• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Fortune 500
    • Fortune 500
    • Fortune Sea 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place To Work
  • Tech
    • Tech
    • Ai
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-suite
    • Ceo Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Novavax

Novavax

Page 2 of 2

EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health

EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares

By Christiaan Hetzner
December 20, 2021
Novavax COVID-19 vaccine’s long-delayed global rollout will start in Indonesia, fueling hope for more equitable distribution
International

Novavax COVID-19 vaccine’s long-delayed global rollout will start in Indonesia, fueling hope for more equitable distribution

By Grady McGregor
November 2, 2021
A WHO-approved Novavax vaccine could upstage mRNA jabs—if it can solve its manufacturing delays
International

A WHO-approved Novavax vaccine could upstage mRNA jabs—if it can solve its manufacturing delays

By Grady McGregor
September 24, 2021
CYPRUS-HEALTH-VIRUS-VACCINE
Health

Novavax shares pop after clinching COVID vaccine supply deal with European Union

By Sophie Mellor
August 5, 2021

Most Popular

  • Success
    Billionaire boss of South Korean construction giant is encouraging his workers to have children with a $75,000 bonus
    By Orianna Rosa Royle
  • Success
    Amazon founder Jeff Bezos says ‘millions of people’ will be living in space by 2045—and robots will commute on our...
    By Orianna Rosa Royle
  • Success
    Billionaire bosses like Jeff Bezos and Reid Hoffman denounce work-life balance—and some think working nonstop is key to...
    By Emma Burleigh
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.